Atlas Trials

Whole Cell Pertussis

13 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Whole Cell Pertussis

RecordFirmDate
Study to Evaluate the Immunogenicity and Reactogenicity of a Booster Dose of GSK2036874A Vaccine in Healthy Toddlers (NCT01106092)GlaxoSmithKline2010-05-13
Immuno & Safety Study With 2 Formulations of DTPw-HBV/HIB When Given at Birth With Hepatitis B at 2, 4 and 6 Mths.Age. (NCT00316680)GlaxoSmithKline2006-03-01
Lot-to-lot Consistency of Tritanrix™-HepB/Hib-MenAC & Its Non-inferiority vs Tritanrix™-HepB/Hiberix™ in Infants (NCT00197275)GlaxoSmithKline2006-02-01
Safety Study of Tritanrix-HepB/Hib-MenAC, Tritanrix-HepB/Hiberix, and Mencevax ACWY Vaccines in Children (NCT00228917)GlaxoSmithKline2005-06-16
Immune Memory of DTPw-HBV/Hib Vaccine Following Primary Vaccination, Immuno & Reacto of a Booster Dose Given in Infants (NCT00169442)GlaxoSmithKline2005-02-10
Immunogenicity & Safety Study of a Vaccine Against Meningitis in Infants (2,4,6 Months) After a Hepatitis B Birth Dose. (NCT00317161)GlaxoSmithKline2004-08-01
Safety Study of a Vaccine Against Meningitis in Infants (2,4 & 6 Months Age) After a Birth Dose of Hepatitis B. (NCT00317187)GlaxoSmithKline2004-06-08
Assess if Immune Response of GSK Biologicals' Tritanrix™-HepB/Hib-MenAC Given Without or With Hepatitis B Vaccine at Birth is at Least as Good as Tritanrix™-HepB/Hiberix™ Without Hepatitis B Vaccine at Birth, When Given to Healthy Infants (NCT00290303)GlaxoSmithKline2004-05-01
Safety Study of a Vaccine Against Meningitis in Infants ( 2,4 & 6 Months Age) After a Birth Dose of Hepatitis B. (NCT00317135)GlaxoSmithKline2003-12-11
A Study to Assess Antibody Persistence, Boostability & Safety in Previously Primed Subjects. (NCT00317174)GlaxoSmithKline2003-07-01

Track Whole Cell Pertussis automatically

Every clearance here is in the API, with alerts when new ones post.